APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Budesonide (BUD)

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Budesonide (BUD) Market Outlook and Growth Opportunities 2026

Report ID 173973020421 December 2025199 pages

Choose your research edition.

Industry ResearchBudesonide (BUD) Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Budesonide (BUD) Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Budesonide (BUD) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Budesonide (BUD) Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Budesonide (BUD) Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Budesonide (BUD) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Budesonide (BUD) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Budesonide (BUD) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Budesonide (BUD) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Budesonide (BUD) market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Budesonide (BUD) market include Chiesi Farmaceutici, Cipla, Cosmo Pharmaceuticals, Dr. Falk Pharma, Lunan Better Pharmaceutical, Orion, Shanghai Sine Promod Pharmaceutical, Synmosa Biopharma and AstraZeneca, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Budesonide (BUD) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Budesonide (BUD) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Budesonide (BUD) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Budesonide (BUD) market size, projected growth trends, production technologies, key applications, and end-use industries.

Budesonide (BUD) Segment by Company

Chiesi Farmaceutici

Cipla

Cosmo Pharmaceuticals

Dr. Falk Pharma

Lunan Better Pharmaceutical

Orion

Shanghai Sine Promod Pharmaceutical

Synmosa Biopharma

AstraZeneca

Mylan

Sandoz

Teva

Budesonide (BUD) Segment by Type

Pill

Inhaler

Nasal Spray

Budesonide (BUD) Segment by Application

Nose Disease Treatment

Respiratory Disease Treatment

Inflammatory Bowel Disease Treatment

Budesonide (BUD) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Budesonide (BUD) status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Budesonide (BUD) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Budesonide (BUD) significant trends, drivers, influence factors in global and regions.

6. To analyze Budesonide (BUD) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Budesonide (BUD) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Budesonide (BUD) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Budesonide (BUD).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Budesonide (BUD) market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Budesonide (BUD) industry.

Chapter 3: Detailed analysis of Budesonide (BUD) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Budesonide (BUD) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Budesonide (BUD) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Budesonide (BUD) Industry Trends Table 2. Budesonide (BUD) Industry Drivers Table 3. Budesonide (BUD) Industry Opportunities and Challenges Table 4. Budesonide (BUD) Industry Restraints Table 5. Global Budesonide (BUD) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Budesonide (BUD) Revenue Share by Company (2021-2026) Table 7. Global Budesonide (BUD) Sales Volume by Company (k tons) & (2021-2026) Table 8. Global Budesonide (BUD) Sales Volume Share by Company (2021-2026) Table 9. Global Budesonide (BUD) Average Price (US$/ton) of Company (2021-2026) Table 10. Global Budesonide (BUD) Company Ranking, (2024-2026) & (USD Million) Table 11. Global Budesonide (BUD) Key Company Manufacturing Base & Headquarters Table 12. Global Budesonide (BUD) Company, Product Type & Application Table 13. Global Budesonide (BUD) Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Budesonide (BUD) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Pill Table 18. Significant Companies of Inhaler Table 19. Significant Companies of Nasal Spray Table 20. Global Budesonide (BUD) Sales Volume by Type 2021 VS 2025 VS 2032 (k tons) Table 21. Global Budesonide (BUD) Sales Volume by Type (2021-2026) & (k tons) Table 22. Global Budesonide (BUD) Sales Volume by Type (2027-2032) & (k tons) Table 23. Global Budesonide (BUD) Sales Volume Share by Type (2021-2026) Table 24. Global Budesonide (BUD) Sales Volume Share by Type (2027-2032) Table 25. Global Budesonide (BUD) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Budesonide (BUD) Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Budesonide (BUD) Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Budesonide (BUD) Sales Value Share by Type (2021-2026) Table 29. Global Budesonide (BUD) Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Nose Disease Treatment Table 31. Significant Companies of Respiratory Disease Treatment Table 32. Significant Companies of Inflammatory Bowel Disease Treatment Table 33. Global Budesonide (BUD) Sales Volume by Application 2021 VS 2025 VS 2032 (k tons) Table 34. Global Budesonide (BUD) Sales Volume by Application (2021-2026) & (k tons) Table 35. Global Budesonide (BUD) Sales Volume by Application (2027-2032) & (k tons) Table 36. Global Budesonide (BUD) Sales Volume Share by Application (2021-2026) Table 37. Global Budesonide (BUD) Sales Volume Share by Application (2027-2032) Table 38. Global Budesonide (BUD) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Budesonide (BUD) Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Budesonide (BUD) Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Budesonide (BUD) Sales Value Share by Application (2021-2026) Table 42. Global Budesonide (BUD) Sales Value Share by Application (2027-2032) Table 43. Global Budesonide (BUD) Sales by Region: 2021 VS 2025 VS 2032 (k tons) Table 44. Global Budesonide (BUD) Sales by Region (2021-2026) & (k tons) Table 45. Global Budesonide (BUD) Sales Market Share by Region (2021-2026) Table 46. Global Budesonide (BUD) Sales by Region (2027-2032) & (k tons) Table 47. Global Budesonide (BUD) Sales Market Share by Region (2027-2032) Table 48. Global Budesonide (BUD) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Budesonide (BUD) Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Budesonide (BUD) Sales Value Share by Region (2021-2026) Table 51. Global Budesonide (BUD) Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Budesonide (BUD) Sales Value Share by Region (2027-2032) Table 53. Global Budesonide (BUD) Market Average Price (US$/ton) by Region (2021-2026) Table 54. Global Budesonide (BUD) Market Average Price (US$/ton) by Region (2027-2032) Table 55. Global Budesonide (BUD) Sales by Country: 2021 VS 2025 VS 2032 (k tons) Table 56. Global Budesonide (BUD) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Budesonide (BUD) Sales by Country (2021-2026) & (k tons) Table 58. Global Budesonide (BUD) Sales Market Share by Country (2021-2026) Table 59. Global Budesonide (BUD) Sales by Country (2027-2032) & (k tons) Table 60. Global Budesonide (BUD) Sales Market Share by Country (2027-2032) Table 61. Global Budesonide (BUD) Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Budesonide (BUD) Sales Value Market Share by Country (2021-2026) Table 63. Global Budesonide (BUD) Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Budesonide (BUD) Sales Value Market Share by Country (2027-2032) Table 65. Chiesi Farmaceutici Company Information Table 66. Chiesi Farmaceutici Business Overview Table 67. Chiesi Farmaceutici Budesonide (BUD) Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 68. Chiesi Farmaceutici Budesonide (BUD) Product Portfolio Table 69. Chiesi Farmaceutici Recent Development Table 70. Cipla Company Information Table 71. Cipla Business Overview Table 72. Cipla Budesonide (BUD) Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 73. Cipla Budesonide (BUD) Product Portfolio Table 74. Cipla Recent Development Table 75. Cosmo Pharmaceuticals Company Information Table 76. Cosmo Pharmaceuticals Business Overview Table 77. Cosmo Pharmaceuticals Budesonide (BUD) Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 78. Cosmo Pharmaceuticals Budesonide (BUD) Product Portfolio Table 79. Cosmo Pharmaceuticals Recent Development Table 80. Dr. Falk Pharma Company Information Table 81. Dr. Falk Pharma Business Overview Table 82. Dr. Falk Pharma Budesonide (BUD) Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 83. Dr. Falk Pharma Budesonide (BUD) Product Portfolio Table 84. Dr. Falk Pharma Recent Development Table 85. Lunan Better Pharmaceutical Company Information Table 86. Lunan Better Pharmaceutical Business Overview Table 87. Lunan Better Pharmaceutical Budesonide (BUD) Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 88. Lunan Better Pharmaceutical Budesonide (BUD) Product Portfolio Table 89. Lunan Better Pharmaceutical Recent Development Table 90. Orion Company Information Table 91. Orion Business Overview Table 92. Orion Budesonide (BUD) Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 93. Orion Budesonide (BUD) Product Portfolio Table 94. Orion Recent Development Table 95. Shanghai Sine Promod Pharmaceutical Company Information Table 96. Shanghai Sine Promod Pharmaceutical Business Overview Table 97. Shanghai Sine Promod Pharmaceutical Budesonide (BUD) Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 98. Shanghai Sine Promod Pharmaceutical Budesonide (BUD) Product Portfolio Table 99. Shanghai Sine Promod Pharmaceutical Recent Development Table 100. Synmosa Biopharma Company Information Table 101. Synmosa Biopharma Business Overview Table 102. Synmosa Biopharma Budesonide (BUD) Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 103. Synmosa Biopharma Budesonide (BUD) Product Portfolio Table 104. Synmosa Biopharma Recent Development Table 105. AstraZeneca Company Information Table 106. AstraZeneca Business Overview Table 107. AstraZeneca Budesonide (BUD) Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 108. AstraZeneca Budesonide (BUD) Product Portfolio Table 109. AstraZeneca Recent Development Table 110. Mylan Company Information Table 111. Mylan Business Overview Table 112. Mylan Budesonide (BUD) Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 113. Mylan Budesonide (BUD) Product Portfolio Table 114. Mylan Recent Development Table 115. Sandoz Company Information Table 116. Sandoz Business Overview Table 117. Sandoz Budesonide (BUD) Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 118. Sandoz Budesonide (BUD) Product Portfolio Table 119. Sandoz Recent Development Table 120. Teva Company Information Table 121. Teva Business Overview Table 122. Teva Budesonide (BUD) Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 123. Teva Budesonide (BUD) Product Portfolio Table 124. Teva Recent Development Table 125. Key Raw Materials Table 126. Raw Materials Key Suppliers Table 127. Budesonide (BUD) Distributors List Table 128. Budesonide (BUD) Customers List Table 129. Research Programs/Design for This Report Table 130. Authors List of This Report Table 131. Secondary Sources Table 132. Primary Sources List of Figures Figure 1. Budesonide (BUD) Product Image Figure 2. Global Budesonide (BUD) Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Budesonide (BUD) Sales Value (2021-2032) & (US$ Million) Figure 4. Global Budesonide (BUD) Sales (2021-2032) & (k tons) Figure 5. Global Budesonide (BUD) Sales Average Price (US$/ton) & (2021-2032) Figure 6. Global Budesonide (BUD) Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Pill Image Figure 10. Inhaler Image Figure 11. Nasal Spray Image Figure 12. Global Budesonide (BUD) Sales Volume by Type (2021 VS 2025 VS 2032) & (k tons) Figure 13. Global Budesonide (BUD) Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Budesonide (BUD) Sales Volume Share by Type (2021-2032) Figure 15. Global Budesonide (BUD) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Budesonide (BUD) Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Budesonide (BUD) Sales Value Share by Type (2021-2032) Figure 18. Nose Disease Treatment Image Figure 19. Respiratory Disease Treatment Image Figure 20. Inflammatory Bowel Disease Treatment Image Figure 21. Global Budesonide (BUD) Sales Volume by Application (2021 VS 2025 VS 2032) & (k tons) Figure 22. Global Budesonide (BUD) Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Budesonide (BUD) Sales Volume Share by Application (2021-2032) Figure 24. Global Budesonide (BUD) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Budesonide (BUD) Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Budesonide (BUD) Sales Value Share by Application (2021-2032) Figure 27. Global Budesonide (BUD) Sales by Region: 2021 VS 2025 VS 2032 (k tons) Figure 28. Global Budesonide (BUD) Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Budesonide (BUD) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Budesonide (BUD) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Budesonide (BUD) Sales Value (2021-2032) & (US$ Million) Figure 32. North America Budesonide (BUD) Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Budesonide (BUD) Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Budesonide (BUD) Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Budesonide (BUD) Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Budesonide (BUD) Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Budesonide (BUD) Sales Value (2021-2032) & (US$ Million) Figure 38. South America Budesonide (BUD) Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Budesonide (BUD) Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Budesonide (BUD) Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Budesonide (BUD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Budesonide (BUD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Budesonide (BUD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Budesonide (BUD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Budesonide (BUD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Budesonide (BUD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Budesonide (BUD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Budesonide (BUD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Budesonide (BUD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Budesonide (BUD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Budesonide (BUD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Budesonide (BUD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Budesonide (BUD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Budesonide (BUD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Budesonide (BUD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Budesonide (BUD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Budesonide (BUD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Budesonide (BUD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Budesonide (BUD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Budesonide (BUD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Budesonide (BUD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Budesonide (BUD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Budesonide (BUD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Budesonide (BUD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Budesonide (BUD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Budesonide (BUD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Budesonide (BUD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Budesonide (BUD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Budesonide (BUD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Budesonide (BUD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Budesonide (BUD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Budesonide (BUD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Budesonide (BUD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Budesonide (BUD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Budesonide (BUD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Budesonide (BUD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Budesonide (BUD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Budesonide (BUD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Budesonide (BUD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Budesonide (BUD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Budesonide (BUD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Budesonide (BUD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Budesonide (BUD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Budesonide (BUD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Budesonide (BUD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Budesonide (BUD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Budesonide (BUD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Budesonide (BUD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Budesonide (BUD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Budesonide (BUD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Budesonide (BUD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Budesonide (BUD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Budesonide (BUD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Budesonide (BUD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Budesonide (BUD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Budesonide (BUD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Budesonide (BUD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Budesonide (BUD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Budesonide (BUD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Budesonide (BUD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Budesonide (BUD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Budesonide (BUD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Budesonide (BUD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Budesonide (BUD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Budesonide (BUD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Budesonide (BUD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Budesonide (BUD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Budesonide (BUD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Budesonide (BUD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Budesonide (BUD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Budesonide (BUD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Budesonide (BUD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Budesonide (BUD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Budesonide (BUD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Budesonide (BUD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Budesonide (BUD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Budesonide (BUD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Budesonide (BUD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Budesonide (BUD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Budesonide (BUD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Budesonide (BUD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Budesonide (BUD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Budesonide (BUD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Budesonide (BUD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Budesonide (BUD) Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Budesonide (BUD) Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Pill
  • Inhaler
  • Nasal Spray
Applications
  • Nose Disease Treatment
  • Respiratory Disease Treatment
  • Inflammatory Bowel Disease Treatment
Companies covered
  • Chiesi Farmaceutici
  • Cipla
  • Cosmo Pharmaceuticals
  • Dr. Falk Pharma
  • Lunan Better Pharmaceutical
  • Orion
  • Shanghai Sine Promod Pharmaceutical
  • Synmosa Biopharma
  • AstraZeneca
  • Mylan
  • Sandoz
  • Teva

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Budesonide (BUD) Sales Value (2021-2032)
  4. 1.2.2 Global Budesonide (BUD) Sales Volume (2021-2032)
  5. 1.2.3 Global Budesonide (BUD) Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Budesonide (BUD) Market Dynamics
  1. 2.1 Budesonide (BUD) Industry Trends
  2. 2.2 Budesonide (BUD) Industry Drivers
  3. 2.3 Budesonide (BUD) Industry Opportunities and Challenges
  4. 2.4 Budesonide (BUD) Industry Restraints
3 Budesonide (BUD) Market by Company
  1. 3.1 Global Budesonide (BUD) Company Revenue Ranking in 2025
  2. 3.2 Global Budesonide (BUD) Revenue by Company (2021-2026)
  3. 3.3 Global Budesonide (BUD) Sales Volume by Company (2021-2026)
  4. 3.4 Global Budesonide (BUD) Average Price by Company (2021-2026)
  5. 3.5 Global Budesonide (BUD) Company Ranking (2024-2026)
  6. 3.6 Global Budesonide (BUD) Company Manufacturing Base and Headquarters
  7. 3.7 Global Budesonide (BUD) Company Product Type and Application
  8. 3.8 Global Budesonide (BUD) Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Budesonide (BUD) Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Budesonide (BUD) Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Budesonide (BUD) Market by Type
  1. 4.1 Budesonide (BUD) Type Introduction
  2. 4.1.1 Pill
  3. 4.1.2 Inhaler
  4. 4.1.3 Nasal Spray
  5. 4.2 Global Budesonide (BUD) Sales Volume by Type
  6. 4.2.1 Global Budesonide (BUD) Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Budesonide (BUD) Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Budesonide (BUD) Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Budesonide (BUD) Sales Value by Type
  10. 4.3.1 Global Budesonide (BUD) Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Budesonide (BUD) Sales Value by Type (2021-2032)
  12. 4.3.3 Global Budesonide (BUD) Sales Value Share by Type (2021-2032)
5 Budesonide (BUD) Market by Application
  1. 5.1 Budesonide (BUD) Application Introduction
  2. 5.1.1 Nose Disease Treatment
  3. 5.1.2 Respiratory Disease Treatment
  4. 5.1.3 Inflammatory Bowel Disease Treatment
  5. 5.2 Global Budesonide (BUD) Sales Volume by Application
  6. 5.2.1 Global Budesonide (BUD) Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Budesonide (BUD) Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Budesonide (BUD) Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Budesonide (BUD) Sales Value by Application
  10. 5.3.1 Global Budesonide (BUD) Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Budesonide (BUD) Sales Value by Application (2021-2032)
  12. 5.3.3 Global Budesonide (BUD) Sales Value Share by Application (2021-2032)
6 Budesonide (BUD) Regional Sales and Value Analysis
  1. 6.1 Global Budesonide (BUD) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Budesonide (BUD) Sales by Region (2021-2032)
  3. 6.2.1 Global Budesonide (BUD) Sales by Region: 2021-2026
  4. 6.2.2 Global Budesonide (BUD) Sales by Region (2027-2032)
  5. 6.3 Global Budesonide (BUD) Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Budesonide (BUD) Sales Value by Region (2021-2032)
  7. 6.4.1 Global Budesonide (BUD) Sales Value by Region: 2021-2026
  8. 6.4.2 Global Budesonide (BUD) Sales Value by Region (2027-2032)
  9. 6.5 Global Budesonide (BUD) Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Budesonide (BUD) Sales Value (2021-2032)
  12. 6.6.2 North America Budesonide (BUD) Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Budesonide (BUD) Sales Value (2021-2032)
  15. 6.7.2 Europe Budesonide (BUD) Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Budesonide (BUD) Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Budesonide (BUD) Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Budesonide (BUD) Sales Value (2021-2032)
  21. 6.9.2 South America Budesonide (BUD) Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Budesonide (BUD) Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Budesonide (BUD) Sales Value Share by Country, 2025 VS 2032
7 Budesonide (BUD) Country-level Sales and Value Analysis
  1. 7.1 Global Budesonide (BUD) Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Budesonide (BUD) Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Budesonide (BUD) Sales by Country (2021-2032)
  4. 7.3.1 Global Budesonide (BUD) Sales by Country (2021-2026)
  5. 7.3.2 Global Budesonide (BUD) Sales by Country (2027-2032)
  6. 7.4 Global Budesonide (BUD) Sales Value by Country (2021-2032)
  7. 7.4.1 Global Budesonide (BUD) Sales Value by Country (2021-2026)
  8. 7.4.2 Global Budesonide (BUD) Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Budesonide (BUD) Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Budesonide (BUD) Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Budesonide (BUD) Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Budesonide (BUD) Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Budesonide (BUD) Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Budesonide (BUD) Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Budesonide (BUD) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Budesonide (BUD) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Budesonide (BUD) Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Budesonide (BUD) Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Budesonide (BUD) Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Budesonide (BUD) Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Budesonide (BUD) Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Budesonide (BUD) Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Budesonide (BUD) Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Budesonide (BUD) Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Budesonide (BUD) Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Budesonide (BUD) Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Budesonide (BUD) Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Budesonide (BUD) Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Budesonide (BUD) Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Budesonide (BUD) Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Budesonide (BUD) Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Budesonide (BUD) Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Budesonide (BUD) Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Budesonide (BUD) Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Budesonide (BUD) Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Budesonide (BUD) Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Budesonide (BUD) Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Budesonide (BUD) Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Budesonide (BUD) Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Budesonide (BUD) Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Budesonide (BUD) Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Budesonide (BUD) Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Budesonide (BUD) Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Budesonide (BUD) Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Budesonide (BUD) Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Budesonide (BUD) Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Budesonide (BUD) Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Budesonide (BUD) Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Budesonide (BUD) Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Budesonide (BUD) Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Budesonide (BUD) Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Budesonide (BUD) Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Budesonide (BUD) Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Budesonide (BUD) Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Budesonide (BUD) Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Budesonide (BUD) Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Budesonide (BUD) Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Budesonide (BUD) Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Budesonide (BUD) Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Budesonide (BUD) Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Budesonide (BUD) Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Budesonide (BUD) Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Budesonide (BUD) Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Budesonide (BUD) Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Budesonide (BUD) Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Budesonide (BUD) Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Budesonide (BUD) Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Budesonide (BUD) Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Budesonide (BUD) Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Budesonide (BUD) Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Budesonide (BUD) Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Budesonide (BUD) Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Budesonide (BUD) Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Budesonide (BUD) Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Budesonide (BUD) Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Budesonide (BUD) Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Budesonide (BUD) Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Budesonide (BUD) Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Budesonide (BUD) Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Budesonide (BUD) Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Budesonide (BUD) Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Budesonide (BUD) Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Budesonide (BUD) Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Budesonide (BUD) Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Budesonide (BUD) Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Budesonide (BUD) Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Budesonide (BUD) Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Budesonide (BUD) Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Budesonide (BUD) Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Budesonide (BUD) Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Budesonide (BUD) Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Budesonide (BUD) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Chiesi Farmaceutici
  2. 8.1.1 Chiesi Farmaceutici Company Information
  3. 8.1.2 Chiesi Farmaceutici Business Overview
  4. 8.1.3 Chiesi Farmaceutici Budesonide (BUD) Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Chiesi Farmaceutici Budesonide (BUD) Product Portfolio
  6. 8.1.5 Chiesi Farmaceutici Recent Developments
  7. 8.2 Cipla
  8. 8.2.1 Cipla Company Information
  9. 8.2.2 Cipla Business Overview
  10. 8.2.3 Cipla Budesonide (BUD) Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Cipla Budesonide (BUD) Product Portfolio
  12. 8.2.5 Cipla Recent Developments
  13. 8.3 Cosmo Pharmaceuticals
  14. 8.3.1 Cosmo Pharmaceuticals Company Information
  15. 8.3.2 Cosmo Pharmaceuticals Business Overview
  16. 8.3.3 Cosmo Pharmaceuticals Budesonide (BUD) Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Cosmo Pharmaceuticals Budesonide (BUD) Product Portfolio
  18. 8.3.5 Cosmo Pharmaceuticals Recent Developments
  19. 8.4 Dr. Falk Pharma
  20. 8.4.1 Dr. Falk Pharma Company Information
  21. 8.4.2 Dr. Falk Pharma Business Overview
  22. 8.4.3 Dr. Falk Pharma Budesonide (BUD) Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Dr. Falk Pharma Budesonide (BUD) Product Portfolio
  24. 8.4.5 Dr. Falk Pharma Recent Developments
  25. 8.5 Lunan Better Pharmaceutical
  26. 8.5.1 Lunan Better Pharmaceutical Company Information
  27. 8.5.2 Lunan Better Pharmaceutical Business Overview
  28. 8.5.3 Lunan Better Pharmaceutical Budesonide (BUD) Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Lunan Better Pharmaceutical Budesonide (BUD) Product Portfolio
  30. 8.5.5 Lunan Better Pharmaceutical Recent Developments
  31. 8.6 Orion
  32. 8.6.1 Orion Company Information
  33. 8.6.2 Orion Business Overview
  34. 8.6.3 Orion Budesonide (BUD) Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Orion Budesonide (BUD) Product Portfolio
  36. 8.6.5 Orion Recent Developments
  37. 8.7 Shanghai Sine Promod Pharmaceutical
  38. 8.7.1 Shanghai Sine Promod Pharmaceutical Company Information
  39. 8.7.2 Shanghai Sine Promod Pharmaceutical Business Overview
  40. 8.7.3 Shanghai Sine Promod Pharmaceutical Budesonide (BUD) Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Shanghai Sine Promod Pharmaceutical Budesonide (BUD) Product Portfolio
  42. 8.7.5 Shanghai Sine Promod Pharmaceutical Recent Developments
  43. 8.8 Synmosa Biopharma
  44. 8.8.1 Synmosa Biopharma Company Information
  45. 8.8.2 Synmosa Biopharma Business Overview
  46. 8.8.3 Synmosa Biopharma Budesonide (BUD) Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Synmosa Biopharma Budesonide (BUD) Product Portfolio
  48. 8.8.5 Synmosa Biopharma Recent Developments
  49. 8.9 AstraZeneca
  50. 8.9.1 AstraZeneca Company Information
  51. 8.9.2 AstraZeneca Business Overview
  52. 8.9.3 AstraZeneca Budesonide (BUD) Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 AstraZeneca Budesonide (BUD) Product Portfolio
  54. 8.9.5 AstraZeneca Recent Developments
  55. 8.10 Mylan
  56. 8.10.1 Mylan Company Information
  57. 8.10.2 Mylan Business Overview
  58. 8.10.3 Mylan Budesonide (BUD) Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Mylan Budesonide (BUD) Product Portfolio
  60. 8.10.5 Mylan Recent Developments
  61. 8.11 Sandoz
  62. 8.11.1 Sandoz Company Information
  63. 8.11.2 Sandoz Business Overview
  64. 8.11.3 Sandoz Budesonide (BUD) Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Sandoz Budesonide (BUD) Product Portfolio
  66. 8.11.5 Sandoz Recent Developments
  67. 8.12 Teva
  68. 8.12.1 Teva Company Information
  69. 8.12.2 Teva Business Overview
  70. 8.12.3 Teva Budesonide (BUD) Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Teva Budesonide (BUD) Product Portfolio
  72. 8.12.5 Teva Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Budesonide (BUD) Value Chain Analysis
  2. 9.1.1 Budesonide (BUD) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Budesonide (BUD) Sales Mode & Process
  6. 9.2 Budesonide (BUD) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Budesonide (BUD) Distributors
  9. 9.2.3 Budesonide (BUD) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst